(R)-3-(N-methylpyrrolidin-2-ylmethyl)-5-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives as high affinity h5-HT1B/1D ligands

被引:5
作者
Egle, I [1 ]
MacLean, N [1 ]
Demchyshyn, L [1 ]
Edwards, L [1 ]
Slassi, A [1 ]
Tehim, A [1 ]
机构
[1] NPS Pharmaceut Inc, Mississauga, ON L4V 1V7, Canada
关键词
D O I
10.1016/S0960-894X(03)00779-0
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of (R)- 3-(N-methylpyrrolidin-2-ylmethyl)-5-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives (2) have been prepared using parallel synthesis, and their structure-activity relationship studied. High affinity human 5-HT1B/1D (h5-HT1B/1D) ligands have been identified. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3419 / 3421
页数:3
相关论文
共 16 条
[11]   5-[(3-NITROPYRID-2-YL)AMINO]INDOLES - NOVEL SEROTONIN AGONISTS WITH SELECTIVITY FOR THE 5-HT1D RECEPTOR - VARIATION OF THE C3 SUBSTITUENT ON THE INDOLE TEMPLATE LEADS TO INCREASED 5-HT1D RECEPTOR SELECTIVITY [J].
MACOR, JE ;
BLANK, DH ;
FOX, CB ;
LEBEL, LA ;
NEWMAN, ME ;
POST, RJ ;
RYAN, K ;
SCHMIDT, AW ;
SCHULZ, DW ;
KOE, BK .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (16) :2509-2512
[12]   EPIDEMIOLOGY OF HEADACHE IN A GENERAL-POPULATION - A PREVALENCE STUDY [J].
RASMUSSEN, BK ;
JENSEN, R ;
SCHROLL, M ;
OLESEN, J .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1991, 44 (11) :1147-1157
[13]  
Russell M G, 1999, IDrugs, V2, P37
[14]   5-alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonists [J].
Slassi, A ;
Edwards, L ;
O'Brien, A ;
Meng, CQ ;
Xin, T ;
Seto, C ;
Lee, DKH ;
MacLean, N ;
Hynd, D ;
Chen, C ;
Wang, H ;
Kamboj, R ;
Rakhit, S .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (15) :1707-1709
[15]   Novel serotonergic and non-serotonergic migraine headache therapies [J].
Slassi, A ;
Isaac, M ;
Arora, J .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (04) :625-649
[16]   Coronary side-effect potential of current and prospective antimigraine drugs [J].
VanDenBrink, AM ;
Reekers, M ;
Bax, WA ;
Ferrari, MD ;
Saxena, PR .
CIRCULATION, 1998, 98 (01) :25-30